EVs from melanoma patients consist of the melanoma-specific protein, very late antigen, tyrosinase-related protein-2, MET, caveolin-1, and Hsp70 as compared to the healthy control, rendering them a potential biomarker in melanoma [102]. This evidence concerns the gene DCT and melanoma.